Brooks Automation and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus in Cleveland, Ohio. The two-story biorepository is managed by Azenta Life Sciences, Brooks’ recently re-branded life sciences division, and includes ultra-cold and cryogenic storage. The new facility increases biobanking capacity at Cleveland Clinic and will help accelerate translational research.

“Biobanking is essential for the evolution of personalized medicine for conditions, such as heart disease, cancer and epilepsy,” said Serpil Erzurum, M.D., Cleveland Clinic’s Chief Research and Academic Officer. Azenta Life Sciences operates biorepository facilities across the United States and around the world. All sample and material management facilities utilize one global, interconnected platform for complete sample visibility and maximum control. The new biorepository allows researchers to more quickly advance laboratory discoveries into new treatments for patients.

“The storage of biological samples safely and efficiently is an integral part of the research process allowing researchers to focus on breakthroughs in areas, such as personalized medicine and therapeutic development,” added Sarah Eckenrode, Ph.D., Vice President, Sample & Repository Solutions, Azenta Life Sciences. “The onsite sample biorepository standardizes sample collection, processing and storage protocols to increase scalability and efficiencies for Cleveland Clinic’s highvalue collections of biological material.”